Two multicenter Phase I randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Doxil® or Caelyx® in advanced ovarian cancer

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, July 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 51 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 162 followers.

Two multicenter Phase I randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Doxil® or Caelyx® in advanced ovarian cancer. https://t.co/7dX3RthxZp

12 Jul 2018

Reply Repost Favourite